Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cellsRenier Myburgh, Markus G. Manz, Jonathan D. Kiefer et al.|Leukemia|2020Cited by 90
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivšek, Berend Snijder, Paul Kachel et al.|Nature Cancer|2023Cited by 42
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burdenRahel Schwotzer, B. Gerber, Clemens B. Caspar et al.|Hematological Oncology|2019Cited by 34
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancerSanaz Taromi, Robert Zeiser, Elke Firat et al.|Cancer Letters|2022Cited by 32
Anti-CD117 CAR T cells incorporating a safety switch eradicate human acute myeloid leukemia and hematopoietic stem cellsChiara F. Magnani, Markus G. Manz|Molecular Therapy — Oncolytics|2023Cited by 31